A study of the effects of acarbose on glucose metabolism in patients predisposed to developing diabetes: the Dutch acarbose intervention study in persons with impaired glucose tolerance (DAISI)
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Background: We hypothesized that acarbose would delay conversion from impaired glucose tolerance (IGT) to type 2 diabetes by alleviating postprandial hyperglycaemia. Our study's main objective was to investigate the effect of acarbose in IGT‐persons on their 2‐h plasma glucose level and beta‐cell function. Subjects and Methods: The study included a random sample of 45–70‐year‐old residents of Hoorn, Netherlands, with mean fasting plasma glucose < 7.8 mmol/L and mean 2‐h plasma glucose of 8.6–11.1 mmol/L (measured by two successive oral glucose tolerance tests). After a qualification period, participants were randomized to acarbose treatment or placebo. Insulin secretion and insulin sensitivity were measured by hyperglycaemic clamp. After a 3‐year treatment, analyses were performed of both the intention‐to‐treat and the per‐protocol groups. Results: Of the 12 093 residents who received postal invitations, 118 participants were randomized. The mean difference of the post‐load plasma glucose after 3 years, was − 1.16 mmol/L (95% CI: − 2.03; − 0.17). The absolute risk reduction for diabetes was 6% (95% CI: − 9; 21). No effect was seen on insulin secretion and insulin sensitivity. Conclusions: In patients with IGT, treatment with acarbose was associated with beneficial effects on 2‐h plasma glucose levels but not with improvement of beta‐cell function. Copyright © 2008 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 2×
“In a previous large multi-centre intervention trial in persons with IGT (STOP-NIDDM), acarbose, an alpha-glucosidase inhibitor, delayed conversion to type 2 diabetes [15–20].”
BackgroundChiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., Laakso, M., & for The STOP-NIDDM Trial Research Group (2003) · JAMA · doi:10.1001/jama.290.4.486 · Cited by 1,624
Harris, M. I., Hadden, W. C., Knowler, W. C., & Bennett, P. H. (1987) · Diabetes · doi:10.2337/diab.36.4.523 · Cited by 1,096
Haffner, S. M. (1990) · JAMA · doi:10.1001/jama.1990.03440210043030 · Cited by 668 · cited 1×
“The World Health Organization distinguishes this glucose intolerance category for its two-fold risk of cardiovascular disease [4–9].”
BackgroundImpaired Glucose Tolerance in the U. S. Population
Harris, M. I. (1989) · Diabetes Care · doi:10.2337/diacare.12.7.464 · Cited by 179
Cited by
Possible effects of dietary polyphenols on sugar absorption and digestion
Williamson, G. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200511 · Cited by 389
Haw, J. S., Galaviz, K. I., Straus, A. N., Kowalski, A. J., Magee, M. J., Weber, M. B., Wei, J., Narayan, K. M. V., & Ali, M. K. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.6040 · Cited by 354
“62) (Figure 3).(33,44,55-73) Insulin sensitizers (metformin, rosiglitazone, and pioglitazone) achieved an RR reduction of 53% (RR, 0.”
BackgroundSiu, A. L., & on behalf of the U.S. Preventive Services Task Force* (2015) · Annals of Internal Medicine · doi:10.7326/m15-2345 · Cited by 319
Hopper, I., Billah, B., Skiba, M., & Krum, H. (2011) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/1741826711421687 · Cited by 149
Selph, S., Dana, T., Blazina, I., Bougatsos, C., Patel, H., & Chou, R. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2221 · Cited by 134
“One trial found that, compared with placebo, acarbose was associated with greater risk for withdrawal because of adverse events (47).”
BackgroundInfluential
Metadata
- Authors
- Nijpels, G., Boorsma, W., Dekker, J. M., Kostense, P. J., Bouter, L. M., & Heine, R. J.
- Venue
- Diabetes/Metabolism Research and Reviews
- Publisher
- Wiley
- Published
- 2008-08-29
- Volume
- 24
- Issue
- 8
- Pages
- 611-616
- ISSN
- 1520-7552 (ISSN-L)
- 1520-7560
- OpenAlex
- W2166142258
- Cited by
- 42
- References
- 6
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A study of the effects of acarbose on glucose metabolism in patients predisposed to developing diabetes: the Dutch acarbose intervention study in persons with impaired glucose tolerance (DAISI). https://app.cochat.ai/papers/10.1002/dmrr.839
- The paper
- Nijpels, G., Boorsma, W., Dekker, J. M., Kostense, P. J., Bouter, L. M., & Heine, R. J. (2008). A study of the effects of acarbose on glucose metabolism in patients predisposed to developing diabetes: the Dutch acarbose intervention study in persons with impaired glucose tolerance (DAISI). Diabetes/Metabolism Research and Reviews. https://doi.org/10.1002/dmrr.839
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.